The Cannigma

APRIL 12, 2023

MoreBetter, creators of the Releaf App, is using this real world data to push back against the claim that there’s no evidence that CBN can help people sleep. In September 2021, MoreBetter hosted a self-reported data collection with this CBN tincture offered to participants for free of charge from CBDistillery. Back to our study.

Sleep 133

Sleep Data Tincture Research and Development 133

SpeedWeed

MARCH 30, 2021

THE UK’s first National Health Service patients registry will start collating data from Thursday this week in a significant move for medical cannabis in the country. However, with the database not yet available to the nation’s private clinics there are concerns over the quality and volume of data it will garner.

Data 52

Data Patients Clinical Trials Business 52

Cannabis Chronicles

MAY 22, 2019

SPOKANE — Researchers at Washington State University are teaming up with the Puyallup Tribe of Indians in an effort to chart the tribe’s outcomes prescribing medicinal marijuana to patients. This partnership with WSU and Qwibil will help us research the safety and efficacy of cannabis as medicine for our patients’ use.”.

Medicine 140

Medicine Research and Development Data Collective 140

Cannabis Law Report

JUNE 4, 2021

– Drug Demonstrates Efficacy and Safety in Advanced Prostate Cancer Patients. Nasdaq: AIKI ) (“AIkido” or the “Company”) today announced that positive Phase 1 testing data was presented at the 2021 ASCO Annual Meeting June 4 , 2021. Declining circulating tumor cell (CTC) count in treated patients.

Data 100

Data Research and Development Clinical Trials Therapy 100

Veriheal

MAY 26, 2022

But one area of cannabis medicine is still lagging behind—research. Patients around the world are in need of natural, alternative medical solutions, and Realm of Caring (RoC) is on a mission to serve them. RoC also works to increase patients’ access to medical cannabis by helping U.S. Bringing Cannabis Into Mainstream Medicine.

Advocacy 98

Advocacy Patients Clinical Trials Education 98

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).

Consumption 109

Consumption Patients Research and Development Data 109

The Cannigma

JANUARY 16, 2021

Listen & Subscribe: Finding the right cannabis product can be a daunting task for anyone, let alone a new medical patient without any guidance. “That’s where we’re trying to fill that need and plug that gap and help individuals inform their purchase decision.” So like example, anxiety or stress.

Data 100

Data Research and Development Patients Strains 100

The Cannigma

FEBRUARY 2, 2021

In a new survey of German patients with Parkinson’s disease, 8% of patients reported using cannabis products. However, the survey also revealed that, among the Parkinson’s disease patients , there was a noticeable knowledge gap concerning the different methods of consumption available and the individual effects of THC and CBD.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

TheAnswerPage

JANUARY 11, 2022

Are you able to answer your patients’ medical marijuana questions? Also, a recent systematic review of healthcare professionals’ “cannabis knowledge” reported “there was a unanimous lack of self-perceived knowledge surrounding all aspects of medicinal cannabis” (2). million medical marijuana patients nationwide.

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

AUGUST 24, 2022

Results from the third Cannabis as Medicine study. The third Cannabis as Medicine Survey (CAMS20) follows on from CAMS16 and CAMS18, and includes 1,600 people using medical cannabis between September 2020 and January 2021. More work is required to enhance health provider education regarding medicinal cannabis. 25 August 2022.

Medicine 52

Medicine Legalization Chronic Pain Access 52

Cannabis Law Report

JANUARY 23, 2020

Report: Cannabis Users’ Sensitive Data Exposed in Data Breach. Led by internet privacy researchers Noam Rotem and Ran Locar, vpnMentor’s research team discovered a data breach in THSuite, a point-of-sale system in the cannabis industry. THSuite Company Profile. Timeline of Discovery and Owner Reaction. But rare are these times.

Data 59

Data Dispensary Patients Medicine 59

Veriheal

DECEMBER 9, 2022

Cannabis Helps Cancer Patients Ditch Opiates, Study Finds. This new stud y looked at insurance claim data from 2012-2017 for 38,189 individuals who had been diagnosed with cancer. The patients came from 34 states that had not legalized medical cannabis by Jan. Let’s dive into this week’s cannanews. Let us know in the comments!

Patients 96

Patients Cannabis Data Legalization 96

Cannabis Law Report

JULY 27, 2021

His first initiative is co-authoring an original study on epilepsy using survey data gathered from RoC’s innovative Observational Research Registry (ORR). Schlienz and colleagues have published a paper summarizing ORR data from individuals with epilepsy in the medical journal Epilepsy & Behavior.

Data 105

Data Epilepsy Research and Development Clinical Trials 105

SpeedWeed

MARCH 14, 2021

Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Through advanced data collection and the application of sophisticated algorithms, usable data is now available to help marijuana businesses: Predict trends. Met consumer demands. Reduce costs.

Data 52

Data Research and Development Marijuana Collective 52

MMJ Recs

JUNE 15, 2022

The best pain management physicians collaborate with the patient to develop a treatment regimen that works best for them as an individual. Unique Pain Medicine. With three offices in NYC, Brooklyn, and Long Island, Unique Pain Medicine is conveniently located and takes multiple insurance plans.

Patients 52

Patients Treatment Clinical Trials Therapy 52

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. billion, servicing nearly 340,000 active patients.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Cannabis Law Report

FEBRUARY 2, 2022

The double-blind, randomised, placebo-controlled clinical trial took place over two years between 2017 and 2019 at the Center for Medicinal Cannabis Research at the University of California. As many patients use cannabis-based medicines to aid with sleep, the current detection window is of significant concern.

Medicine 52

Medicine Clinical Trials Consumption Sleep 52

Sensi Seeds

JANUARY 4, 2019

Context of the Medicinal Cannabis Situation. Patients should first meet with a health-care practitioner to determine if cannabis can be beneficial in treating their symptoms. If so, the latter provides patients with a medical certificate required for registration with one of the 132 producers authorized by Health Canada.

Medicine 75

Medicine Research and Development Patients Programs 75

Cannabis Law Report

DECEMBER 11, 2021

The UK’s first and highest-rated medical cannabis clinic, Sapphire Medical Clinics , has today announced that it is reducing the cost of its consultations and appointments for patients enrolled through the Sapphire Access Scheme. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.

Access 52

Access Patients Chronic Pain Treatment 52

Veriheal

APRIL 23, 2024

California was the first state to legalize medicinal cannabis in 1996, right around the time that Gen Z began to enter society. Alternative medicines are a priority among Gen Z, who are moving away from traditional Western options and instead using natural wellness to support the mind and body.

Chronic Pain 109

Chronic Pain Data Edibles Sleep 109

Cannabis Law Report

JUNE 23, 2021

Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. By 2024, the medicinal cannabis market within the United Kingdom is predicted to be worth nearly US$1.3 in real terms to £4.97 to reach 3.2

Programs 100

Programs Data Events Collective 100

Veriheal

MAY 18, 2023

annually — is one of the most common reasons why medical marijuana is sought out by patients in the United States, Canada, and beyond. Using this information, they composed a list of valuable suggestions for consuming cannabis to treat various types of chronic pain. Chronic pain —a condition that affects 50.2 million people in the U.S.

Chronic Pain 98

Chronic Pain Treatment Research and Development Patients 98

Cannabis Law Report

AUGUST 14, 2019

Let’s take a closer look at five key ways big data and technology are directly impacting the industry. Big Data Streamlines the Marijuana Regulatory Process and Helps Close the Scientific Research Gap. Therefore, the growing marijuana market lacks the clinical data needed to help marijuana businesses create new and better products.

Data 45

Data Research and Development Marijuana Collective 45

SpeedWeed

APRIL 3, 2021

A new survey out of Texas reveals that, according to the data they gathered, 61 percent of the state’s medical cannabis users turn to medical cannabis as a replacement for prescription drugs. . The survey was conducted online between August 11, 2020, and October 6, 2020, and recruited participants through medical cannabis patient networks.

Patients 52

Patients Chronic Pain Policy History 52

The Joint Blog

JULY 14, 2021

Medicinal CBD is helping seniors improve their quality of life. The low THC content ensures that you can reap all its medicinal benefits without having to get high. Some CBD oil manufactures give incorrect information claiming it can cure cancer or force it into remission. Some adults over the age of 65 are using CBD.

Medicine 52

Medicine CBD Chronic Pain Blood Pressure 52

Cannabis Law Report

AUGUST 10, 2021

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. As two emergent complementary medicines, many parallels exist between the medical cannabis industry and the currently developing psychedelic medicine industry.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Cannabis Law Report

JULY 13, 2021

The deal with LYPHE Group means that thousands of patients will be the first in Europe to have access to pain relief delivered in a metered dose via Kanabo’s VapePod. Kanabo’s medical line aims to enable patients to move away from the harmful habit of smoking medical cannabis flowers.

Extraction 105

Extraction Vaping Medicine Patients 105

Cannabis Law Report

JULY 19, 2021

First-of-its-kind universal milliliter to milligram calculation has potential to transform rapidly growing plant-based medicines sector. The RYAH MD platform is designed for use by healthcare professionals to remotely monitor and control their patients’ dosing regimens with RYAH’s suite of dose-measuring products. billion by 2027.

Therapy 76

Therapy Data Research and Development Events 76

Cannabis Law Report

JULY 19, 2021

Pondering Pot report that according to…… Data from Canview’s online portal has shown that despite the high prices of medical cannabis in Australia, end costs to patients are slowly coming down. Note that the prices are ‘Price to Patient’ and are only recommended prices. Tilray Full Spectrum 10:10 40ml. ANTG Solace.

Oil 105

Oil CBD Patients Data 105

Cannabis Law Report

MARCH 22, 2020

A data firm is warning those infected with the novel coronoavirus to avoid consuming products that contain tetrahydrocannabinol (THC), the main psychoactive component of cannabis. Data CEO Julie Armstrong said her company knows the COVID-19 affects the population in a similar way to influenza. World Health Organization (WHO).

THC 59

THC Clinical Trials Data Consumption 59

Veriheal

APRIL 11, 2022

The final goal is to introduce medicinal cannabis products to the pharmaceutical drug market. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website. “You This means that U.S.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Cannabis Law Report

SEPTEMBER 7, 2022

Since the legalisation of medical cannabis in the UK in 2018, there is little education surrounding medical cannabis and how it can help a large variety of conditions, should traditional medicine leave patients with an ‘unmet clinical need.’ . I use my prescription to treat my anxiety, ADHD+ and Autism.

Patients 52

Patients Conditions Treatment Education 52

Cannabis Law Report

JULY 30, 2019

Cannabis-based products will be allowed to bypass usual processes required for medicines in New Zealand and go directly onto the market without any proof of safety or effectiveness. This unprecedented proposal is contained in the government’s consultation document on giving greater access to medicinal cannabis.

Medicine 40

Medicine Clinical Trials Safety Access 40

Alchimia

JANUARY 26, 2016

Spanish Observatory of Medicinal Cannabis. Therefore, users of medicinal cannabis can be completely confident. For this reason, we stress the need for truthful, accurate and scientific information on cannabis and its therapeutic purposes. Cordially, Spanish Observatory of Medicinal Cannabis.

Medicine 48

Medicine Clinical Trials Data Cannabinoids 48

Veriheal

AUGUST 31, 2020

These students showed knowledge and passion for the future of cannabis and posed revolutionary ideas rooted in their training across business, agriculture, biochemistry, public health, pharmacology, medicine, and liberal arts. . Essay: “Integrating Research and Medicine: Cannabis Related Treatment for Neurodegenerative Diseases”.

Research and Development 117

Research and Development Education Agriculture Patients 117

The Cannigma

AUGUST 31, 2021

Barely a quarter of cannabis users trust their doctor to provide them with reliable information about medical cannabis and how to use it to treat their medical or health conditions, according to a recent survey. One of the more extensive reports of this nature was published in the Journal of Cannabis Research in 2018.

Education 101

Education Clinical Trials Medicine Policy 101